相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
Aijia Zhang et al.
NEOPLASIA (2020)
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile
Annalisa Astolfi et al.
CANCERS (2020)
Current state of the art and emerging pharmacotherapy for uterine leiomyosarcomas
Matteo Tantari et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs
Yuxing Liao et al.
NUCLEIC ACIDS RESEARCH (2019)
Discovery of Aberrant Alteration of Genome in Colorectal Cancer by Exome Sequencing
Yuanzi Liang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Secondary cytoreductive surgery in recurrent uterine leiomyosarcoma: a multi-institutional study
Nicolo Bizzarri et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
SHARPIN-mediated regulation of protein arginine methyltransferase 5 controls melanoma growth
Hironari Tamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma
Hideaki Tsuyoshi et al.
CANCER SCIENCE (2018)
Integrative genomic and transcriptomic analysis of leiomyosarcoma
Priya Chudasama et al.
CANCER RESEARCH (2018)
Phosphorylation of zinc channel ZIP7 drives MAPK, PI3K and mTOR growth and proliferation signalling
T. Nimmanon et al.
METALLOMICS (2017)
SHARPIN Facilitates p53 Degradation in Breast Cancer Cells
Huijie Yang et al.
NEOPLASIA (2017)
Signatures derived from increase in SHARPIN gene copy number are associated with poor prognosis in patients with breast cancer
Diane Ojo et al.
BBA CLINICAL (2017)
CRAVAT 4: Cancer-Related Analysis of Variants Toolkit
David L. Masica et al.
CANCER RESEARCH (2017)
Targeted Exome Sequencing Profiles Genetic Alterations in Leiomyosarcoma
Narasimhan P. Agaram et al.
GENES CHROMOSOMES & CANCER (2016)
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
William D. Tap et al.
LANCET (2016)
Sharpin promotes hepatocellular carcinoma progression via transactivation of Versican expression
Y. Tanaka et al.
ONCOGENESIS (2016)
RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells
Zhong Zheng et al.
CANCER CELL INTERNATIONAL (2015)
Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR
Hui Yang et al.
NATURE PROTOCOLS (2015)
Comprehensive characterization of the genomic alterations in human gastric cancer
Juan Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Activation of Nuclear Factor κB Pathway and Downstream Targets Survivin and Livin by SHARPIN Contributes to the Progression and Metastasis of Prostate Cancer
Yiming Zhang et al.
CANCER (2014)
Management of advanced uterine leiomyosarcoma
David M. Hyman et al.
CURRENT OPINION IN ONCOLOGY (2014)
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Bernard Leroy et al.
HUMAN MUTATION (2014)
Gynecologic Cancer InterGroup (GCIG) Consensus Review Uterine and Ovarian Leiomyosarcomas
Martee L. Hensley et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis
Yong Chen et al.
ONCOLOGY REPORTS (2013)
Copy number variation detection and genotyping from exome sequence data
Niklas Krumm et al.
GENOME RESEARCH (2012)
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing
Daniel C. Koboldt et al.
GENOME RESEARCH (2012)
Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization
Mohammad Raish et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Expression of G Protein-Coupled Receptor 19 in Human Lung Cancer Cells Is Triggered by Entry into S-Phase and Supports G2-M Cell-Cycle Progression
Stefan Kastner et al.
MOLECULAR CANCER RESEARCH (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in Sarcomagenesis
Moriko Ito et al.
CLINICAL CANCER RESEARCH (2011)
Low frequency of somatic mutations in uterine sarcomas: A molecular analysis and review of the literature
S. Murray et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi Barretina et al.
NATURE GENETICS (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Genetic aberrations in soft tissue leiomyosarcoma
Jilong Yang et al.
CANCER LETTERS (2009)
ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer cells
Kathryn M. Taylor et al.
ENDOCRINOLOGY (2008)
分享论文
